Inflammation and ischemic heart disease: The next therapeutic target? Eduardo M. Vilela; Ricardo Fontes-Carvalho;

Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis Jaime Pinho; Miguel Carvalho; Mariana Paiva; Nuno Teixeira-Tavares; Cristina Costa-Santos; Carla Sousa;

Management of dyslipidemia in diabetic patients: The situation in primary health care units Débora Alves Fonseca; Joana Lamas; Leonor Luz Duarte;